A detailed history of Harbour Investments, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 23,121 shares of ABBV stock, worth $4.47 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
23,121
Previous 22,313 3.62%
Holding current value
$4.47 Million
Previous $4.06 Million 2.41%
% of portfolio
0.14%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $125,070 - $146,054
808 Added 3.62%
23,121 $3.97 Million
Q1 2024

Jul 22, 2024

BUY
$159.82 - $182.1 $144,157 - $164,254
902 Added 4.21%
22,313 $4.06 Million
Q4 2023

Feb 16, 2024

BUY
$137.6 - $154.97 $391,059 - $440,424
2,842 Added 15.31%
21,411 $3.32 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $519,397 - $601,279
3,888 Added 26.48%
18,569 $2.77 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $4,505 - $5,606
34 Added 0.23%
14,681 $1.98 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $27,765 - $31,975
192 Added 1.33%
14,647 $2.33 Million
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $1.28 Million - $1.54 Million
-9,276 Reduced 39.09%
14,455 $2.34 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $172,437 - $219,224
1,253 Added 5.57%
23,731 $3.64 Million
Q4 2021

Feb 16, 2022

SELL
$107.43 - $135.93 $5.76 Million - $7.29 Million
-53,653 Reduced 70.47%
22,478 $3.04 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $415,279 - $471,404
-3,903 Reduced 4.88%
76,131 $8.21 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $425,364 - $473,880
4,043 Added 5.32%
80,034 $9.02 Million
Q1 2021

Aug 17, 2021

BUY
$102.3 - $112.62 $7.51 Million - $8.27 Million
73,398 Added 2830.62%
75,991 $8.22 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $265,263 - $292,023
2,593 New
2,593 $281,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.